D
Daniel F. Kiernan
Researcher at University of Illinois at Chicago
Publications - 34
Citations - 801
Daniel F. Kiernan is an academic researcher from University of Illinois at Chicago. The author has contributed to research in topics: Visual acuity & Macular degeneration. The author has an hindex of 13, co-authored 31 publications receiving 707 citations. Previous affiliations of Daniel F. Kiernan include University of Illinois at Urbana–Champaign & University of Chicago.
Papers
More filters
Journal ArticleDOI
Spectral-Domain Optical Coherence Tomography: A Comparison of Modern High-Resolution Retinal Imaging Systems
TL;DR: Advances in high-resolution imaging of the anterior and posterior segment have revealed new in vivo details of anatomic, physiologic, and pathologic data for the practice of ophthalmology, and as the technology develops, SD OCT will continue to provide new insights about ocular structure and disease.
Journal ArticleDOI
Prospective comparison of cirrus and stratus optical coherence tomography for quantifying retinal thickness.
Daniel F. Kiernan,Seenu M. Hariprasad,Eric K. Chin,Claire L. Kiernan,James Rago,William F. Mieler +5 more
TL;DR: Comparing Cirrus Fourier-domain optical coherence tomography with Stratus time-domain OCT for imaging retinal diseases and quantifying retinal thickness (RT) of all nine OCT zones, central macular thickness, and average Macular thickness in eyes with and without macular edema is compared.
Journal ArticleDOI
Epidemiology of the association between anticoagulants and intraocular hemorrhage in patients with neovascular age-related macular degeneration
Daniel F. Kiernan,Seenu M. Hariprasad,Irene M Rusu,Sahil V. Mehta,William F. Mieler,Rama D. Jager +5 more
TL;DR: All three daily AP/AC types were significantly associated with an increased risk of the development intraocular hemorrhage in patients with neovascular AMD, whereas gender, hypertension, and diabetes were not.
Journal ArticleDOI
The use of intraocular corticosteroids
TL;DR: Although intraocular corticosteroid injections have a limited duration of action requiring frequent re-treatment, and significant side effects including cataract and glaucoma development, intraocular injections may be of benefit in certain ocular disorders.
Journal ArticleDOI
Effects of Green Diode Laser in the Treatment of Pediatric Coats Disease
TL;DR: Green diode laser therapy can be an effective treatment for advanced Coats disease, even in the presence of a moderate to severely elevated retinal detachment.